Focus: Millicent Pharma is a women's health specialist focused on menopausal treatments, headquartered in Dundalk, Ireland. The company operates as a commercial-stage pharmaceutical entity with a highly concentrated portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Millicent Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core revenue driver representing 99% of company revenue; approaching loss of exclusivity creates critical business risk.
Help build intelligence for Millicent Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Millicent Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Secondary product at peak lifecycle with 7-year exclusivity runway; minimal revenue contribution relative to FEMRING.
Newest addition in growth phase with longest LOE protection (2041); potential future revenue contributor but currently unquantified.
Minor branded product with approaching exclusivity loss and unclear commercial traction.
Generic/ANDA product in post-LOE phase; commodity product with eroded margins.
Generic/ANDA product in post-LOE phase with minimal differentiation and declining commercial relevance.
1 discontinued, 2 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo